
Accessories
Cannabinoid receptors found mainly in immune tissues and the peripheral nervous system, linked to anti-inflammatory effects.
CB2 receptors are cannabinoid receptors found mainly in immune system tissues, the spleen, tonsils, and the peripheral nervous system. Unlike CB1 receptors, which are concentrated in the brain, CB2 receptors play a primary role in regulating inflammation and immune responses throughout the body.
When activated, CB2 receptors help modulate immune cell behavior, reducing the release of pro-inflammatory cytokines and promoting tissue healing. CBD has been shown to influence CB2 receptor activity, which may partly explain its reported anti-inflammatory benefits. The terpene beta-caryophyllene is unique in that it can directly bind to CB2 receptors, making it the only known dietary terpene with direct cannabinoid receptor activity.
CB2 receptors are a major focus of pharmaceutical research because targeting them could provide anti-inflammatory and pain-relieving benefits without the psychoactive effects associated with CB1 activation. Studies have explored CB2-targeted therapies for conditions including arthritis, inflammatory bowel disease, neuropathic pain, and even neurodegenerative diseases. For cannabis consumers, understanding CB2 receptors helps explain why CBD-rich and caryophyllene-rich strains are often recommended for inflammatory conditions.